INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement to Establish Expanded Publicly Traded Life Science Company

INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO”), a healthcare services company focused on expanding access to advanced fertility treatment worldwide, and NAYA Biosciences Inc. (“NAYA”), a company dedicated to increasing patient access to breakthrough treatments in oncology and regenerative medicine, jointly announce that they have entered into a definitive merger agreement (the “Merger”) for INVO to acquire NAYA Biosciences in an all-stock transaction. Following the merger, NAYA Biosciences plans to operate as a NASDAQ-listed group of agile, disruptive, high-growth companies dedicated to increasing patient access to life-transforming treatments in oncology (“NAYA Oncology”), fertility (“NAYA Fertility”), and regenerative medicine (“NAYA Regenerative Medicine”).

Read the full article: INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement to Establish Expanded Publicly Traded Life Science Company //

Source: https://www.prnewswire.com/news-releases/invo-bioscience-and-naya-biosciences-announce-definitive-merger-agreement-to-establish-expanded-publicly-traded-life-science-company-301964066.html

Leave a Comment

Your email address will not be published.

Scroll to Top